SINGLE CELL TECHNOLOGY, INC.
AbTheneum, an antibody discovery platform that captures and analyzes single-cell data to generate antibody leads
Follows are private to you and power your alerts
Updated · singlecelltechnology.com
- Sector
- Biotech
- Headquarters
- SAN JOSE, CA
- Founded
- 2008
- Latest Form D
- $2.1M, Feb 2021
- Total capital
- $2.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.2M
- 2 Form D · last Feb 2021
- 68 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 17 pending · first 2018
- Rank in peer group#59 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$2.1M
- Private capital raisedForm D · SEC · 1st filing$105K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#59 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Chun-Nan ChenResearcherExecutive Officer, DirectorLinked by 2 patents
- David O SasseenDirectorNamed in SEC Form D filings
- JAMES O BOWLBYExecutive Officer, Director, PromoterNamed in SEC Form D filings
- James O Bowlby, Jr.DirectorNamed in SEC Form D filings
- Jun O TienDirectorNamed in SEC Form D filings
- RAMIN R NAJAFIDirectorNamed in SEC Form D filings
Show all 9 people
- RICHARD O JORGENSENDirector, PromoterNamed in SEC Form D filings
- ROBERT R TUFTSDirectorNamed in SEC Form D filings
- Yen-Ming O HsuDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 19- PendingAnti-sars CORONAVIRUS-2 Nucleocapsid Protein AntibodiesUSPTOApplication 18268192
- PendingAnti-sars CORONAVIRUS-2 Spike Protein AntibodiesUSPTOApplication 18017566
- PendingANTI-TIM-3 AntibodiesUSPTOApplication 17621509
Show all 19 patent records
- Anti-sars CORONAVIRUS-2 Nucleocapsid Protein AntibodiesFeb 22, 2024 · Application 18268192Pending
- Anti-sars CORONAVIRUS-2 Spike Protein AntibodiesSep 21, 2023 · Application 18017566Pending
- ANTI-TIM-3 AntibodiesSep 7, 2023 · Application 17621509Pending
- Anti-tigit AntibodiesOct 20, 2022 · Application 17621597Pending
- Method Of Screening A Plurality Of Single Secreting Cells For Functional ActivityAug 16, 2018 · Application 15951109Pending
- Method Of Screening A Plurality Of Single Secreting Cells For Functional ActivityApr 17, 2018 · US 9,944,983Granted
- Method Of Obtaining Antibodies Of Interest And Nucleotides Encoding SameJan 23, 2018 · US 9,873,871Granted
- ANTI-TIM-3 AntibodiesApplication 62864835Pending
- Anti-tigit AntibodiesApplication 62864842Pending
- Method Of Screening A Plurality Of Single Secreting Cells For Functional ActivityApplication PCTUS2012069205Pending
- Method Of Obtaining Antibodies Of Interest And Nucleotides Encoding SameApplication PCTUS2009002086Pending
- Multi-well SystemApplication PCTUS2009002106Pending
- Method Of Screening Single Cells For The Production Of Biologically Active AgentsApplication PCTUS2009002122Pending
- Anti-sars CORONAVIRUS-2 Nucleocapsid Protein AntibodiesApplication PCTUS2021064214Pending
- Anti-sars CORONAVIRUS-2 Spike Protein AntibodiesApplication PCTUS2021071013Pending
- Anti-sars CORONAVIRUS-2 Nucleocapsid Protein AntibodiesApplication 63127902Pending
- Anti-sars CORONAVIRUS-2 Spike Protein AntibodiesApplication 63057162Pending
- Anti-tigit AntibodiesApplication PCTUS2020038925Pending
- ANTI-TIM-3 AntibodiesApplication PCTUS2020038997Pending
Related companies, and why
- Kayak Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Slate MedicinesSimilar federal contract value in Biotech · null in contracts
- Commense Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Virion Therapeutics, LLCSimilar federal contract value in Biotech · null in contracts
- SunnyBay BioTech, Inc.Similar federal contract value in Biotech · null in contracts
- PROSETTA BIOCONFORMATICS INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .